- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
|Donald Ingber, speaker at the 2008 NanoBio Symposium at Johns Hopkins University.
Credit: Harvard University
It was the simple elegance of a Kenneth Snelson sculpture that inspired Harvard Medical School Professor Donald Ingber to adopt a more mechanical view of the growth and development of cells and tissue. Ingber will share some of his insights at the NanoBio Symposium on May 2, 2008, hosted by Johns Hopkins University's Institute for NanoBioTechnology.
Ingber is the Judah Folkman Professor of Vascular Biology in the Department of Pathology at Harvard Medical School, and Departments of Pathology and Surgery at Children's Hospital Boston. He also serves as acting co-director of Harvard's Institute for Biologically Inspired Engineering and Director at Children's Hospital of Harvard's Center for Integration in Medicine and Innovative Technology.
At the symposium Ingber plans to discuss "bio-inspired nanotechnology."
"Nanotechnologists dream of building things that are as multifunctional, capable and flexible as living materials," Ingber says. "I will share what we have learned about how chemical and physical signals, as well as soluble stimuli, regulate cell behavior so that nanotechnologists can leverage this information to build materials that mimic living materials."
The spark that fired Ingber's imagination to investigate cells in novel ways occurred decades ago when, as an undergraduate at Yale, he took a course in sculpture and became intrigued by the forces at work in Snelson's tensegrity models. (The term "tensegrity" was coined from "tension" and "integrity" by architect and designer R. Buckminster Fuller, the namesake of the 60-carbon atom "fullerenes" or "bucky balls.")
Ingber has devoted his career to studying how living cells assemble themselves at the nanometer scale using tensegrity architecture by distributing minute forces over the extracellular matrix (ECM) and intracellular cytoskeleton. ECM, also known as the "basement membrane" in the epithelial lining tissues of our bodies, provides structure and support to cells, as well as aids in cell adhesion, anchoring, and cell-cell communication. A break in the ECM tells pathologists that the cells growing there may be cancerous; 90 percent of the time this is true.
"Pathologists view the extracellular matrix as a host barrier through which a malignant tumor must gain the ability to invade," Ingber says. "I view it as something that regulates cell growth and pattern formation, and when it goes awry, it can lead to cancer development."
To this end, Ingber investigates how cells go about sensing their surroundings and how the ECM contributes to tumor formation. He has authored more than 250 papers of this subject, including seminal publications on how cell surface receptors—integrins—mediate intracellular signals with the ECM and how cytoskeletal networks regulate tissue development.
* To view some of Ingber's interactive models demonstrating tensegrity in cells, click here.
* To read more about the Ingber Lab, click here.
Other confirmed speakers for the 2008 Johns Hopkins University Nano-Bio Symposium include:
* Andrew D. Maynard, Ph.D.
Chief Science Advisor, Project on Emerging Nanotechnologies
Woodrow Wilson International Center for Scholars
* Paras N. Prasad, Ph.D.
Distinguished Professor and Samuel P. Capen Chair of Chemistry
Director, Institute for Lasers, Photonics, and Biophotonics
University of Buffalo, The State University of New York
* Jeffery A. Schloss, Ph.D.
Co-chair, Trans-NIH NANO Task Force
Program Director, Technology Development Coordination
National Human Genome Research Institute, National Institutes of Health
* Jennifer L. West, Ph.D.
Isabel C. Cameron Professor of Bioengineering
Participant registration and guidelines for poster submission will be available soon.
Sponsorships opportunities are available now.
About Institute for NanoBioTechnology
The Institute for NanoBioTechnology at Johns Hopkins University will revolutionize health care by bringing together internationally renowned expertise in medicine, engineering, the sciences, and public health to create new knowledge and groundbreaking technologies.
INBT programs in research, education, outreach, and technology transfer are designed to foster the next wave of nanobiotechnology innovation.
Approximately 150 faculty are affiliated with INBT and are also members of the following Johns Hopkins institutions: Krieger School of Arts and Sciences, Whiting School of Engineering, School of Medicine, Bloomberg School of Public Health, and Applied Physics Laboratory.
For more information, please click here
INBT’s media relations coordinator
Copyright © Institute for NanoBioTechnologyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015